Related Experiment Video

Updated: Jun 23, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

[Natural compounds in chemoprevention of esophageal squamous cell tumors--experimental studies]

Justyna Szumiło1

  • 1Medical University of Lublin, Department of Clinical Pathomorphology, Poland. jszumilo@wp.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|April 25, 2009
PubMed

Insights

Chemoprevention, the use of natural compounds to prevent cancer, shows promise for esophageal squamous cell carcinoma. Certain compounds like diallyl sulfide and resveratrol effectively inhibited tumor formation in rat models.

Area of Science:

  • Oncology
  • Chemoprevention Research
  • Gastrointestinal Cancer

Context:

  • Esophageal squamous cell carcinoma (ESCC) is an aggressive digestive system tumor with a poor prognosis, necessitating effective prevention strategies.
  • Chemoprevention research focuses on identifying compounds that can block carcinogen influence or reverse precancerous lesions.
  • Most preclinical studies utilize rat models exposed to chemical carcinogens like N-nitroso-N-methylbenzylamine (NMBA).

Purpose:

  • To review the chemopreventive properties of various natural compounds and complex diets against esophageal cancer.
  • To identify effective agents and understand their mechanisms of action in blocking or reversing tumor formation.
  • To evaluate the potential of chemoprevention for managing esophageal squamous cell carcinoma.

Summary:

  • Diallyl sulfide and phenethyl isothiocyanate demonstrated significant chemopreventive effects in NMBA-induced rat esophageal cancer models.
  • Lyophilized berries (black raspberries, blackberries, strawberries), tea products, ellagic acid, and resveratrol also exhibited strong efficacy.
  • Mechanisms involve modulating carcinogen-metabolizing enzymes (cytochrome P450), inhibiting DNA adducts, and regulating cell proliferation, apoptosis, and angiogenesis.

Impact:

  • Identifies promising natural compounds for esophageal cancer chemoprevention, including diallyl sulfide, resveratrol, and berry extracts.
  • Elucidates key molecular mechanisms underlying chemopreventive actions, such as enzyme activity modulation and cell cycle regulation.
  • Highlights the need for further research into effective chemopreventive agents while cautioning against agents like perillyl alcohol that may promote lesion development.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...